What to look forward to this week on Contemporary OB/GYN.
You can expect a variety of topics to be covered this week on Contemporary OB/GYN, including:
From the December issue of Contemporary OB/GYN, get the results of this year's State of the Industry survey.
Hear from Linda Fan, MD, about how telehealth has come to the forefront of patient-based care.
Let us know in this week's quiz.
Check back soon for additional updates.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More